RT Journal Article
SR Electronic
T1 Radioiodine Therapy in Patient with Differentiated Thyroid Cancer and End-Stage Renal Disease on Maintenance Hemodialysis: Case Report with Review of Literature
JF Journal of Nuclear Medicine Technology
JO J. Nucl. Med. Technol.
FD Society of Nuclear Medicine
SP 228
OP 232
DO 10.2967/jnmt.121.261979
VO 50
IS 3
A1 Munish Kumar
A1 Karthikeyan Subramanian
A1 Karan Singh Tanwar
A1 Arun Prabhahar
A1 Smita Divyaveer
A1 Ashwani Sood
A1 Bhagwant Rai Mittal
A1 Apurva Sood
YR 2022
UL http://tech.snmjournals.org/content/50/3/228.abstract
AB Surgical resection followed by radioactive iodine (131I) therapy constitutes a standard treatment for differentiated thyroid cancer. 131I is normally excreted through the kidneys, and treatment of patients with end-stage renal disease on hemodialysis requires special attention to the dose of 131I, the timing of dialysis, and radiation safety. We present a case of end-stage renal disease in a postthyroidectomy patient on hemodialysis who required radioactive iodine ablation, and we review the literature.